logo

For the Inventor, By the Inventor

Madrid, Spain

Maria T Diez

This inventor holds 11 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1993-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria T Diez. Retrieved from https://idiyas.com/inventor/maria-t-diez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal11 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1993-1999

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5994412 - Bis-aryl ethers, compositions containing such compounds and methods of (1999-11-30),
2. 5801172 - Antifungal agent from sporomiella minimoides (1998-09-01),
3. 5770587 - Antifungal agents (1998-06-23),
4. 5756472 - Antifungal agent obtained from hormonema (1998-05-26),
5. 5712151 - Antifungal agent (1998-01-27),
6. 5712109 - Antifungal agent produced by arthrinium arundinis ATCC 74359 (1998-01-27),
7. 5702929 - Antifungal agent (1997-12-30),
8. 5348970 - Antifungal compound and compositions containing the compound (1994-09-20),
9. 5276054 - Substituted hexahydrobenzopyran derivatives as angiotensin II antagonists (1994-01-04),
10. 5250424 - Processes for preparing novel squalene synthetase inhibitors (1993-10-05),
11. 5200342 - Squalene synthetase inhibitors and processes therefrom (1993-04-06),

Title: **Maria T. Diez: Pioneering Patents in Pharmaceutical Innovations**

Introduction

Maria T. Diez, an innovative inventor based in Madrid, Spain, holds a remarkable portfolio of 11 patents. Her work encapsulates the essence of scientific advancement, particularly in the realm of pharmaceuticals. With a focus on developing compounds that show promise in cancer treatment and antifungal applications, her inventions contribute significantly to the medical field.

Latest Patents

One of Diez's latest patents pertains to bis-aryl ethers, where she has disclosed a compound demonstrated to possess inhibitory activity against the oncoprotein Raf. This breakthrough could potentially pave the way for new methods of treating cancer. In another noteworthy patent, she introduced a novel antifungal agent derived from Sporomiella minimoides, which exhibits promising antifungal activity, showcasing her diverse expertise in medicinal chemistry.

Career Highlights

Maria has made significant strides during her tenure at Merck & Company, Inc., a leader in global pharmaceuticals. Her drive for innovation reflects her commitment to enhancing therapeutic modalities, with numerous patents that underscore her contribution to science and medicine.

Collaborations

Throughout her career, Diez has collaborated with esteemed colleagues, including Fernando Pelaez and Gerald F. Bills. These collaborations not only highlight her ability to work within multidisciplinary teams but also enhance the collective capacity for innovation within the pharmaceutical industry.

Conclusion

Maria T. Diez stands as a leading inventor in the field of pharmaceuticals, with her patents exemplifying cutting-edge research and development. Her contributions not only benefit the scientific community but also have the potential to significantly improve patient outcomes in cancer treatments and antifungal therapies. With pioneering work like hers, the future of medicine continues to hold promise.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…